Changes in N-terminal pro-B-type natriuretic peptide levels and outcomes in heart failure with preserved ejection fraction: an analysis of the I-Preserve study-Reference-Cited by-同舟云学术

Changes in N-terminal pro-B-type natriuretic peptide levels and outcomes in heart failure with preserved ejection fraction: an analysis of the I-Preserve study

Published:2015-04-29 Issue:8 Volume:17 Page:809-817
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Jhund Pardeep S.¹,Anand Inder S.²,Komajda Michel³,Claggett Brian L.⁴,McKelvie Robert S.⁵,Zile Michael R.⁶,Carson Peter E.⁷,McMurray John J.V.¹

Affiliation:

1. BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences; University of Glasgow; Glasgow UK

2. Veterans Affairs Medical Center and University of Minnesota; Minneapolis MN USA

3. Université Paris 6 and Hospital Pitié-Salpêtrière; Paris France

4. Division of Cardiovascular Medicine; Brigham and Women's Hospital; Boston MA USA

5. Hamilton Health Sciences; McMaster University; Hamilton ON Canada

6. Ralph H. Johnson Veterans Affairs Medical Center and Medical University of South Carolina; Charleston SC USA

7. Georgetown University and Washington DC Veterans Affairs Medical Center; Washington DC USA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ejhf.274/fullpdf

Reference28 articles.

1. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC;McMurray;Eur J Heart Fail,2012

2. Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide;Wedel;Eur J Heart Fail,2009

3. Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial;Anand;Circ Heart Fail,2011

4. Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial;Hartmann;Circulation,2004

5. Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data;Masson;Clin Chem,2006

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive value of NT pro BNP for new‐onset atrial fibrillation in heart failure and preserved ejection fraction;ESC Heart Failure;2024-08-28

2. Association of ventricular–arterial coupling with biomarkers involved in heart failure pathophysiology – the STANISLAS cohort;European Journal of Heart Failure;2024-08-27

3. Longitudinal NT‐proBNP: Associations With Echocardiographic Changes and Outcomes in Heart Failure;Journal of the American Heart Association;2024-05-07

4. Novel Strategies in Diagnosing Heart Failure with Preserved Ejection Fraction: A Comprehensive Literature Review;High Blood Pressure & Cardiovascular Prevention;2024-03-15

5. Atrial Strain and Strain Rate in a General Population: Do These Measures Improve the Assessment of Elevated NT‐proBNP Levels?;Cardiology Research and Practice;2024-01